These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18305392)

  • 1. Prolonged survival of islet allografts in mice treated with rosmarinic acid and anti-CD154 antibody.
    Jung DY; Kim EY; Joo SY; Park JB; Moon C; Kim SH; Sim EY; Joh JW; Kwon CH; Kwon GY; Kim SJ
    Exp Mol Med; 2008 Feb; 40(1):1-10. PubMed ID: 18305392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of simultaneous treatment with 15-deoxyspergualin and monoclonal antibodies to CD45RB and CD154 on murine islet transplantation recipients.
    Jung DY; Lee HJ; Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Lee SK; Joh JW; Kwon GY; Kim SJ
    Transplantation; 2006 Jul; 82(2):188-95. PubMed ID: 16858281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice].
    Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
    Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
    Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.
    Lee SJ; Kim HJ; Byun NR; Park CG
    Cell Transplant; 2020; 29():963689720913876. PubMed ID: 32216448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface camouflage of pancreatic islets using 6-arm-PEG-catechol in combined therapy with tacrolimus and anti-CD154 monoclonal antibody for xenotransplantation.
    Jeong JH; Hong SW; Hong S; Yook S; Jung Y; Park JB; Khue CD; Im BH; Seo J; Lee H; Ahn CH; Lee DY; Byun Y
    Biomaterials; 2011 Nov; 32(31):7961-70. PubMed ID: 21831422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody.
    Appel MC; Banuelos SJ; Greiner DL; Shultz LD; Mordes JP; Rossini AA
    Transplantation; 2004 May; 77(9):1341-9. PubMed ID: 15167588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation.
    Muller YD; Mai G; Morel P; Serre-Beinier V; Gonelle-Gispert C; Yung GP; Ehirchiou D; Wyss JC; Bigenzahn S; Irla M; Heusser C; Golshayan D; Seebach JD; Wekerle T; Bühler LH
    PLoS One; 2010 Apr; 5(4):e10352. PubMed ID: 20436684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term limb allograft survival using anti-CD40L antibody in a murine model.
    Tung TH; Mackinnon SE; Mohanakumar T
    Transplantation; 2003 Mar; 75(5):644-50. PubMed ID: 12640303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of discordant xenogeneic islets using repeated therapy with anti-CD154.
    Bucher P; Gang M; Morel P; Mathe Z; Bosco D; Pernin N; Wekerle T; Berney T; Buhler LH
    Transplantation; 2005 Jun; 79(11):1545-52. PubMed ID: 15940044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression.
    Sánchez-Fueyo A; Domenig C; Strom TB; Zheng XX
    Transplantation; 2002 Sep; 74(6):898-900. PubMed ID: 12364878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of spontaneously diabetic Ins2(akita) mice to allograft tolerance induced by anti-CD154 therapy.
    Bishop NH; Beard KS; Gill RG
    Transplant Proc; 2014; 46(6):2007-9. PubMed ID: 25131095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD154 mAb treatment but not recipient CD154 deficiency leads to long-term survival of xenogeneic islet grafts.
    Mai G; Bucher P; Morel P; Mei J; Bosco D; Andres A; Mathe Z; Wekerle T; Berney T; Bühler LH
    Am J Transplant; 2005 May; 5(5):1021-31. PubMed ID: 15816882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
    Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
    Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.